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Original repOrt: genetic research (Malloy et al. 1999 (Malloy et al. , 2005 (Malloy et al. 2005; Feldman et al. 2007 ). The 1,25 (OH)   2   D   3 activates the VDR, which heterodimerizes with the retinoid X receptor. The VDR then interacts with specific DNA sequences in vitamin D-specific response elements (Hughes et al. 1988; Malloy et al. 1999) .
Through their action on 1,25-dihydroxyvitamin D3 (calcitriol), or 1,25(OH) 2 D 3 , vitamin D receptors are essential in the mediation of bone and mineral metabolism and the control of calcium and phosphate metabolism (Malloy et al. 1999; Feldman et al. 2007; Lee et al. 2007; Arita et al. 2008) . Any mutation in the VDR will alter this function, leading to decreased serum ionized calcium and increased secretion of the parathyroid hormone (PTH), enhanced osteoclastic activity, and greater rates of alkaline phosphatase (Malloy et al. 1999) .
Most mutations in VDR lead to defects in the DNA-or ligand-binding domain assessed by biochemical and molecular analysis (Malloy et al. 1999) . Although deletions and splice site mutations have been detected, the main types of mutations are missense and nonsense (Hewison et al. 1993; Chen et al. 2003) .
After birth, calcium levels are usually within normal range because of calcium transfer from the mother during the fetal period. The first apparent sign of possible HVDRR is alopecia. Blood analysis shows early evidence of elevated alkaline phosphatase and 1,25(OH) 2 D 3 concentration levels (Farese 2007) , caused by primary low calcium levels that in turn engender hyperparathyroidism and the associated cascade of PTH oversecretion and augmented levels of calcium and alkaline phosphatase (Tiosano et al. 2001; Malloy et al. 2005) .
Biological features of HVDRR include rickets or osteomalacia, hypocalcemia, secondary hyperparathyroidism, and hypophosphatemia with partial, total, or no alopecia (Hochberg et al. 1985; Takeda et al. 1987) . Problems similar to those associated with HVDRR (bone pain, muscle weakness, and alopecia of various severities) have been described for hypophosphatemic rickets, a condition that is comparatively less severe than HVDRR and more amenable to treatment. In most affected patients, hypophosphatemia is caused by an X-linked mutation (80% X-linked vs. 20% autosomal recessive), which leads to an increased circulating level of fibroblast growth factor 23, resulting in increased phosphate excretion and decreased alpha-1 hydroxylase activity (Reid et al. 1989 ). The condition is treated with high doses of phosphate and calcitriol.
If HVDRR is not treated, the child's growth is severely affected with bone bending and/or fractures. In advanced conditions of hypocalcemia, subjects suffer from neuromuscular symptoms, which are caused by decreased interaction between calcium and sodium channels; the calcium blocks sodium channels that inhibit depolarization of nerve and muscle fiber (Armstrong and Cota 1999) . Symptoms usually include convulsions, arrhythmias, tetany, and numbness/paresthesias in the hands, feet, and perioral area.
Dental features of affected subjects include hypoplasia, thin dentin, enlarged pulp chambers, severe dental caries, and premature loss (McWhorter and Seale 1991; Seow et al. 1995; Baroncelli et al. 2006) . Histologically, large lacunae are found in dentin, and the pulp horns may reach the dentinoenamel junction (Goodman et al. 1998; Chaussain-Miller et al. 2007 ). These characteristics may lead to dental abscesses even without any apparent caries or trauma to the teeth (Shroff et al. 2002) .
Nearly all dental reports on HVDRR have been clinical observations. Our aims were to report and analyze the oral findings in children with HVDRR in relation to type of mutations underlying the disease and to evaluate the association between dental development and the timing of and response to treatment. For a total perspective on the effect of rickets on dentitional development, a comparison with dental findings in hypophosphatemic rickets is included in the discussion.
Materials and Methods
Four children, aged 2 y 2 mo to 6 y 8 mo, from 3 families were referred from around the country to the American University of Beirut Medical Center pediatric nephrology unit, known for providing expert treatment of HVDRR. They were recruited in the study after clinical diagnosis with the condition (VDDR type IIA) and meeting the following inclusion criteria: radiographic findings of rickets, presence of total or partial alopecia, hypocalcemia, hyperalkaline phosphatasemia, and secondary hyperparathyroidism. After Institutional Review Board-approved signed consent was obtained from the parents, the genomes were analyzed (Andary et al. 2017) , and clinical and radiographic oral findings were recorded longitudinally.
DNA Mutations
The patients (MA, RA, TK, JZ) and their family members had blood samples drawn, and DNA was extracted with the Qiagen DNA extraction kit as previously described (Nemer et al. 2006) . The quantity of the extracted DNA was measured at 260 nm, within the range of 400 to 800 ng/μL. All exons of the VDR gene were amplified by polymerase chain reaction with the Phusion polymerase enzyme from Finzymes (Thermo Fisher Scientific). The samples were then run on a 1.5% agarose gel. Subsequently, the bands that correspond to the product size were cut with surgical blades. DNA was purified with the QIAquick gel extraction kit (28704; Qiagen). Purified DNA sequencing was conducted with the chain terminator method system of 4 reactions and 1 gel on an ABI3100 DNA sequencer (Applied Biosystems) at the Molecular Core Facility at the American University of Beirut. Results were analyzed with the data collection software and later compared with online databases.
Dental Analysis
Dental characteristics of patients with HVDRR were recorded longitudinally (up to 5 y). Analysis included dental photographs and panoramic radiographs. Photographs were taken systematically every 6 mo or when parents reported modification in the child's dental status. Panoramic radiographs were taken as initial records and later when justified for diagnostic reasons, only on the 2 older patients (MA and TK).
Results
Two mutations were found in the studied families: arginine to serine (p.R391S), and histidine to proline (p.H397P). Reported mutations fell in the terminal exon 10 (Andary et al. 2017). All patients had retarded growth and rickets, with very high levels of PTH levels (Table) . They were born to parents with first-degree consanguinity, with additional consanguinity in older generations in 3 children ( JZ, MA, RA). Alopecia was related to the type of mutation (Fig. 1) , as was the response to treatment with high doses of calcium and vitamin D. The 3 subjects (MA, RA, TK) with p.R391S mutation suffered from partial or total alopecia (Fig. 2) and responded well to treatment, while the nonalopecic patient ( JZ) with p.H397P mutation showed no response to treatment (Fig.  3) . Both mutations were registered in the ClinVar gene bank (p.R391S: novel, SCV000299205; p.H397P: novel, SCV000299206).
During the periods of observation, dental findings also varied depending on the type of mutation. Good responders to high doses of vitamin D and calcium, the subjects with p.R391S mutation showed no additional loss of primary teeth, whereas the poor responder JZ (p.H397P mutation) lost additional teeth posteruption (Figs. 2, 3) .
Patients with p.R391S Mutation
MA: When first examined at age 6 y 8 mo, MA was missing the primary maxillary incisors and mandibular incisors and canines, all reportedly lost 2 y earlier. The erupted permanent first molars and mandibular central incisors sustained enamel hypoplasia. The panoramic radiograph revealed hypoplastic enamel on the molars and absence of the maxillary permanent lateral incisors and right second premolar, as well as the mandibular right and left second premolars and right first premolar. No additional tooth loss was noted following successful treatment. All of the patient's permanent incisors eventually emerged with hypoplastic enamel and were later restored along with the permanent first molars. RA: The sister of the previous patient, this child (2 y 6 mo) presented hypoplastic enamel on all primary teeth, premature loss of the mandibular primary central incisors, and delayed eruption of the maxillary primary second molars. Her dental development steered toward normalcy after treatment with high doses of vitamin D and calcium. A panoramic radiograph taken at age 7.5 y disclosed the agenesis of her maxillary right permanent lateral incisor. The erupted permanent teeth did not show enamel abnormality. TK: At age 3 y 3 mo, this patient displayed hypoplastic enamel on all primary teeth, and his maxillary central incisors were mobile. Depicted on the initial panoramic radiograph was the presence of all permanent teeth and the enlarged pulp chambers of primary teeth, but no signs of hypoplastic enamel were observed. Following positive response to treatment, the mobile teeth were well anchored a few months later.
Patient with p.H397P Mutation
When he first presented at age 2 y 2 mo, JZ had very unusual dental findings: the only primary teeth present were the maxillary lateral incisors; the crowns of the maxillary and mandibular primary canines were bulging and palpable under the gingiva; and the maxillary primary left first molar was erupting.
The child never showed any signs of improvement. Serum calcium levels remained very low during the course of treatment despite high doses of medication. The anterior primary teeth that eventually started erupting were lost 3 to 4 wk posteruption. The posterior teeth remained but were not well anchored, with mobility gauged at level 1 to 2 (out of 3 per Miller's classification, 1985) . The child's physical and dental health continuously deteriorated. He was hospitalized several times for tonic seizures secondary to hypocalcemia and for lower respiratory tract infections. At the age of 6 y, JZ had seizures with cardiopulmonary arrest with multilobar pneumonia and failed resuscitation.
Discussion
More than 40 mutations in VDR have been described at the DNA-binding level in all patients with alopecia and at the ligand-binding domain in subjects having normal hair and others displaying alopecia (Malloy et al. 1999; Arita et al. 2008; Zhou et al. 2009 ).
Screening for mutations in the reported patients revealed a novel missense homozygous mutation (ligand-binding domain) in exon 10 changing CAC to CCC (JZ). This alteration corresponded to a shift in amino acids from histidine to proline at position 397, corresponding to the phenotype characterized by absence of alopecia and poor response to treatment. Proline397 is in very close proximity to arginine391, which was mutated to serine in the 3 other children with a different phenotype. When associated with HVDRR, abnormalities at the 391 codon level were found to be a compound heterozygous mutation or associated with a different amino acid mutation (p.R391C; Whitfield et al. 1996; Nguyen et al. 2006) . We report a homozygous p.R391S mutation.
Regardless of the mutation, our series indicates that vitamin D, acting through its receptor VDR, indirectly affects tooth formation through its effect on blood calcium levels. Further tooth formation (in this instance, already root formation) is an indicator of disease alteration through treatment.
All monoradiculated teeth were lost a few weeks posteruption in patient JZ, who did not respond to treatment, whereas the teeth became well anchored in those subjects who benefited from therapy that normalized their blood calcium levels. The hypoplastic enamel observed on permanent teeth in 1 of the subjects with p.R391S mutation (MA) was likely related to the timing of crown formation/calcification of the affected teeth (Logan and Kronfeld 1933) .
During pregnancy, adequate calcium levels are provided via the placenta by the mother and directly through the serum of the fetus, avoiding the negative action of the disease on the ongoing formation and calcification of the developing primary teeth (Brunette 1988) . When calcium levels are provided by nutrition after birth, the pathologic process lowers these levels, impeding the normal formation of the currently developing tooth structures-namely, the roots of primary teeth and crowns of the developing permanent incisors and first molars.
Consequently, the early developing primary teeth lose their anchoring roots. The proper formation of the remaining structures of primary and permanent teeth will depend on the timing of treatment initiation and/or response. If adequate calcium reaches these structures at the time of their formation, the remaining teeth will be normal (Ash and Nelson 2009 ). This process explains why MA, whose treatment was initiated at around age 2 y, had enamel hypoplasia of the crowns of the permanent teeth that started calcification before therapy (Fig. 2) , while his sister RA, for whom treatment was instituted within months after birth, had no signs of enamel anomalies. The agenesis of permanent teeth observed in MA and RA is related to a family history of hypodontia and unlikely associated with the HVDRR condition. Published reports also do not associate the disease with missing teeth (Souza et al. 2013) .
Only partial root formation had occurred at the time of tooth loss in the reported patients. Intraoral eruption has been shown to be independent of root formation (Marks and Schroeder 1996; Wise and King 2008; Wang 2013) , and normal-developing teeth emerge in the mouth before complete root formation (Moorrees et al. 1969) .
Premature loss of teeth in children with rickets is related to RANKL-mediated bone resorption, which appears to be more severe in hypocalcemia than in hypophosphatemia rickets. In both conditions, dental problems are more commonly associated with primary than permanent teeth because the effect of treatment spares the permanent dentition. Also, structural features are observed: hypoplastic enamel, dentin defects, large pulp chambers and enlarged pulp horns (taurodontism), and dental abscesses. The basic disparity between the rickets disorders is in the amount of tooth development at the time of tooth loss.
Comparatively earlier bone loss before root formation in HVDRR results in tooth exfoliation, whereas dental loss in hypophosphatemic rickets occurs after root formation. This difference is caused by extremely high PTH levels in HVDRR patients (Malloy et al. 2011; Isojima et al. 2015 ; Table) , compared with moderate or slightly increased levels in hypophosphatemic subjects (Pradhan et al. 2014; Radlović et al. 2014) . Acting on osteoblasts, PTH increases their production of RANKL, which binds to RANK on osteoclast precursor cells and directs their differentiation, leading to increase in alveolar bone resorption and release of Ca 2+ (Kondo et al. 2002) . The higher the PTH levels, the more severe the alveolar bone resorption.
The rare occurrence of the HVDRR disease (Malloy et al. 1999 (Malloy et al. , 2005 restricted the recruitment of additional subjects. Many children who presented to our pediatric department having symptoms similar to HVDRR suffered from hypophosphatemic rickets, which required a different treatment and had a milder course on the dentition. The limited sample can be only partly overcome by an ongoing monitoring of the reported children throughout growth and the additional recruitment of future referrals.
Although premature loss of teeth was conveyed in prior publications (McWhorter and Seale 1991; Seow et al. 1995; Baroncelli et al. 2006) , our report of oral conditions in relation to type of mutations and response to treatment was warranted at this time. An international registry or regional documentations of the disease, its dental effects, and outcome of treatment shall help establish the needed larger samples for more comprehensive study. Longitudinal research would help assess the generalizability of the present findings and potentially better analyze the biological mechanisms controlling the interaction between drastic calcium deficiency and impeded dental development, as well as level of restored development with amount of calcium rehabilitation. Insights on normal dental growth would also result from these studies.
Conclusion
First, mutations in VDR result in various phenotypes: the p.R391S mutation yielded alopecia, good response to treatment, and relatively well-anchored teeth; the p.H397P mutation was characterized by the absence of alopecia, lack of response to treatment, and tooth loss.
Second, dental development is directly related to blood calcium levels during infancy, essentially impeded with ensuing primary tooth loss when calcium is severely deficient. Timing of treatment and the restoration of normal blood calcium levels affect dental health: when treatment is initiated early (months after birth), fewer primary teeth are lost, and tooth structure is less affected by hypocalcemia. In this context, dental development, a local indicator of the ongoing disease process, reflects on the overall treatment response of the disease. Longitudinal research on a greater number of children is warranted.
Last, differences in dental development between HVDRR and hypophosphatemic rickets apparently relate to the amount of tooth development at the time of tooth loss.
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